---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-295456"
form_type: "8-K"
ticker: "STOK"
cik: "0001623526"
company_name: "Stoke Therapeutics, Inc."
filed_at: "2023-12-14T23:59:59+00:00"
generated_at: "2026-06-07T12:50:40.312210+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Stoke Therapeutics extends headquarters lease to Dec 2026; aggregate rent ~$5.05M

## Summary
- Entered first amendment to lease for corporate HQ and lab at 45-47 Wiggins Ave, Bedford, MA.
- Lease term extended by two years to December 31, 2026.
- Aggregate estimated base rent over extension period approximately $5.05 million.
- Option to further extend for five years at 95% of then-prevailing market rate.

## SEC filing metadata
- accession: 0001193125-23-295456
- form_type: 8-K
- ticker: STOK
- cik: 0001623526
- company_name: Stoke Therapeutics, Inc.
- filed_at: 2023-12-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623526/000119312523295456/0001193125-23-295456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623526/000119312523295456/d523640d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-295456
- JSON: https://secwatch.observer/filing/0001193125-23-295456.json
- Plain text: https://secwatch.observer/filing/0001193125-23-295456.txt

## Key facts
- Material Agreements
  Stoke Therapeutics, Inc. amended First Amendment with Xenon Property, LLC valued at approximately $5.05 million (effective 2023-12-12).
  - Action: amendment
  - Agreement: lease
  - Counterparty: Xenon Property, LLC
  - Value: approximately $5.05 million
  - Effective: 2023-12-12
  source text: On December 12, 2023, Stoke Therapeutics, Inc. (the “ Company ”) entered into a first amendment (the “ First Amendment ”) to its corporate headquarters and laboratory lease agreement with Xenon Property, LLC, as successor-in-interest to ARE-MA Region No. 24, LLC, located at 45-47 Wiggins Avenue, Bedford, Massachusetts (the “ Lease ”), in order to extend the term of the Lease for a period of two years (the “ Lease Extension Period ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623526/000119312523295456/0001193125-23-295456-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.